Control (N=20) MVPt- (N=63) MVPt+ (N=31)
P-Value
Age, years 66.5 (8.7) 74.1 (6.6) 73.7 (6.0) <0.001*|
Men, n (%) 11(55) 25 (40) 13 (42)
BSA, m2 1.7 (0.2) 1.5 (0.2) 1.6 (0.2) <0.001*|
NYHA, n (%) <0.001*|
1 23 (100.0) 0(0) 0(0)
2 0(0) 15 (23.8) 4 (12.9)
3 0(0) 39 (61.9) 20 (64.5)
4 0(0) 9 (14.3) 7 (22.6)
NT-proBNP - 885.2±1298.76 1870.35±2266.97 <0.001
VCA, cm2 0.0 (0.0) 0.6 (0.2) 0.9 (0.3) <0.001*¶|
LVEDVi, mL/m2 46.1 (10.6) 72.3 (15.8) 86.4 (22.0) <0.001*¶|
LVESVi, mL/m2 17.5 (4.7) 28.2 (10.1) 35.0 (14.1) <0.001*¶|
LVEF, % 63.2 (3.3) 60.4 (11.8) 56.4 (17.3) 0.13|
VCW, mm 0.0 (0.0) 8.9 (2.7) 8.8 (1.5) <0.001*|
Etiology, n (%) 0.274
FED - 55 (87) 30 (97)
Barlow - 8 (13) 1 (3)
Flail, n (%) 0(0) 46 (73.0) 29 (93.5) <0.001*¶|
Flail width, mm 0.0 (0.0) 11.8 (3.3) 12.5 (2.9) <0.001*|
Flail gap, mm 0.0 (0.0) 7.3 (2.9) 9.2 (2.2) <0.001*¶|
AML length, mm 21.6 (3.4) 24.5 (3.9) 25.6 (3.9) 0.001*|
PML length, mm 11.9 (1.6) 16.5 (3.4) 18.1 (3.0) <0.001*¶|
AP diameter(2D), mm 30.3 (6.7) 33.3 (4.9) 36.0 (3.2) <0.001¶|
LVEDD, mm 46.2 (2.9) 52.1 (4.8) 55.1 (5.2) <0.001*¶|
LVESD, mm 29.3 (3.4) 31.7 (3.3) 35.4 (6.6) <0.001*¶|
LAA, cm2 18.0 (5.0) 29.1 (8.3) 33.0 (9.5) <0.001*|
sPAP, mmHg - 51.8±18.9 60.8±17.5 0.052